India, March 17 -- Latest study shows a serious link between emergency room wait times and patient survival. One in ten accident and emergency patients (A&E patients) with visible blood in urine ...

ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more ...

In this episode of From Bench to Bedside and Beyond, Dr. Yaw Nyame and patient Dave Lucas discuss the robotic surgical approach that enabled Lucas to carry on with his vacation plans and the value of ...

For Grant Nerren, 2025 was a busy year, full of highs and lows that likely contributed to a certain level of stress. Life was ...

When Janice Johnson went to the hospital for what she thought was food poisoning, she had no idea it would lead to a cancer ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Lung Cancer Group has published a new overview examining how federal environmental policy changes expected in 2026 could affect oversight of asbestos exposure, along with the records and timelines ...

AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...

If you think plastic pollution is something that floats out at sea or washes up on a beautiful Bahamian beach, think again.

Patrick Soon-Shiong is pursuing a public offering for the media company, while juggling healthcare and tech pursuits.

A Brit has become the first patient in Europe to trial a pioneering antibody drug that ‘attaches’ to cancer cells. Brian Holmes, 70, has suffered with metastatic prostate cancer for two years and has ...